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, to ultimate mutagens that were detected in cocultivated Chinese hamster V79 cells. Increases in the frequency ofouabainresistant (or) mutations and sister chromatid exchanges were found in V79 cells only when they were cocultivated with both PAM and the chemical procarcinogens. 7,8-Diol caused higher frequencies of both or mutations and sister chromatid exchanges than did the parent compound, B(a)P. When metabolically activated by PAM the mean Or mutation frequency caused by B(a)P was 9 or mutants/106 surviving V79 cells per 106 PAM and a 10-fold interindividual variation (range, 2-21) was found. The mean Or mutation frequency caused by 7,8-diol was 64 and a ninefold interindividual variation (range, 14-120) was found. In the absence of PAM, the or mutation frequency in V79 cells was (1) . B(a)P may be inhaled into the lulng either directly or it may be combined with carriers such as airborne particulates, including those in the tobacco smoke (2, 3) . Pulmonary macrophages (PAM) phagocytize inhaled foreign particulates that reach the peripheral airways, and generally transport them by the mucociliary system up the respiratory tract to be either expectorated or swallowed. During this journey, PAM may metabolize B(a)P and other carcinogens adsorbed on engulfed particulates and release both activated (proximate and ultimate carcinogens) and deactivated metabolites into the bronchial lumen, which is lined by epithelial cells (4) .
Metabolism of B(a)P in pulmonary minacrophages is of interest both because of potential interactions between PAM and bronchial epithelium in the activation of chemical carcinogens and because of the possible usefulness of PAM as an indicator of B(a)P metabolism in the target tissue, i.e., bronchial epithelium. Human PAM obtained from lung tissues have been shown to contain aryl hydrocarbon hydroxylase (AHH) activity (5, 6) . These mixed function oxidases metabolize B(a)P to form(s) that bind to cellular DNA. A sixfold interindividual variation in AHH activity and a ninefold variation in binding levels of B(a)P to DNA were observed in PAM prepared from 13 individuals (7). A similar observation was reported by McLemore et al. (8) when they compared the levels of AHH in PAM, lung tissues and cultured mitogen-stimulated lymphocytes. They found also a good positive correlation of AHH level in these three tissues and cells from seven individual noncancer patients but no correlation among these three preparations from seven patients with lung cancer.
We recently found that human PAM can metabolize B(a)P to proximate and ultimate mutagens, and cause or mutations in Chinese hamster V79 cells (9) . The or mutation frequency was dependent on the number of cocultivated PAM and on the concentration of either (+) 7,X, 8a-dihydroxy-7,8-dihydrobenzo[a]pyrene (7,8-diol) or B(a)P. Chinese hamster V79 cells do not effectively metabolize either B(a)P or 7,8-diol into ultimate mutagens (10) . In the present report, these studies have been extended to evaluate the ability of PAM from 20 individuals to mediate mutations in V79 cells. In addition, the increase of sister chromatid exchange (SCE) frequency in V79 cells mediated with PAM was studied. Co.) supplemented with 10% heat-inactivated fetal calf serum (Irvine Scientific Co., Irvine, Calif.), pencillin (100 U/ml), streptomycin (100 ,ug/ml), and glutamine (2 mM) (13) . The cultures were dispersed with 0.05% trypsin/EDTA solution (Grand Island Biological Co.) and were subcultured twice a week at a dilution of 1:30 and incubated at 37°C in an atmosphere of 10% C02 in air.
Determination of Or mutations and SCE in V79 cells. In the PAM-mediated mutagenesis assay, the PAM were cultured for [7] [8] d before the addition of the V79 cells to allow AHH activity to reach basal levels (14) and then 5 x 105 V79 cells were added to each 100-mm culture dish containing 1-2 x 106 PAM. Within 4 h of cocultivation, the V79 cells were attached to the dishes and were then exposed to medium containing 1 ,g/ml ofeither B(a)P (15) (9, 13) . SCE were measured in V79 cells by the technique described by Perry and Wolff (16, 17) . One or two dishes ofthe cells in each group were treated with medium containing 10 ,uM bromodeoxyuridine 2-3 h after seeding and kept at 370C in the dark for 28-30 h. Colecemid (0.1 gg/ml) was added for 2 h before the mitotic cells were collected by trypsinization.
To determine the variation caused by experiments conducted at different times, 0.4 ,ug/ml of N-methyl-N-nitro-Nnitrosoguanidine was included in medium of V79 cells at the beginning of the 70-h cocultivation. The cells were then dispersed for selection of or mutants as described above.
RESULTS
Chinese hamster V79 cells attached in the dishes which contained PAM (Fig. 1A) . The V79 cells grew and replaced the cocultivated PAM in the dishes. At the end of cocultivation, most of the PAM were detached and over 80% of the surface area of the dishes was covered by V79 cells (Fig. 1B) . During cocultivation, PAM metabolized either B(a)P or 7,8-diol to ultimate mutagens.
PAM isolated from 20 individuals were tested for their abilities to mediate or mutation in V79 cells. The or mutation frequency in V79 cells cocultivated with PAM in medium containing 1 ,ug/ml B(a)P from 16 individual cases studied to date is shown in Table II increase by B(a)P were observed in the V79 cells (Table IV) . Because both selection of or mutants and scoring of SCE were done in the cells that had been cocultivated and treated under the same conditions, the potential source ofexperimental variation in comparison should be minimized. 7,8-Diol produced 4-10 times more or mutants and 20-30% more SCE than did B(a)P. 7,8-Benzoflavone (1 ,g/ml, an inhibitor of AHH (19) , had no observable effect on the proliferation of V79 cells but almost completely inhibited the increase in the frequencies of or mutation and SCE caused by 7,8-diol and mediated by PAM (Table V) . However, 7,8-benzoflavone did not change the or mutation frequency in V79 cells caused by a direct-acting ultimate carcinogen, B(a)P diol epoxide I (Table V) Induction of or mutation in V79 cells can also be demonstrated by treating PAM with B(a)P adsorbed on ferric oxide particles and then cocultivated with V79 cells suggesting a slowly release of active metabolites of B(a)P in the inhaled and phagocytized particles (22) . PAM migrate into the alveolar spaces in response to inhaled foreign material including particulates in tobacco smoke. They carry the phagocytized particulates up the mucous ciliary transport system where PAM came in close contact with bronchial epithelium and may play in concert with respiratory epithelium in initiation of respiratory carcinomas by the activation of carcinogen. These facts were all consistent with our hypothesis that PAM carry particulates with adsorbed carcinogens from tobacco smoke up to the respiratory tract and may interact with respiratory epithelium in the causation of respiratory cancer.
Our previous studies (9) in the PAMI-mediated mutation assay vere approximiately ninefold. The variation caused by experimental miiethodology wasiminimal. In addition, PAM had been cultivated for 7-8 d before use to minimize metabolic changes cauised by exogenous factors, e.g., tobacco smoking and drug treatments, in the donors; chemical constitutents from cigarette tar were found to induice AHH activity in PAM (5, 23, 24) .
Although PAMn-mediated mutagenicity has not been compared previously aimong individuials, both AHH activity and B(a)P binding to DNA in PAM have been reported. A sixfold variation in AHH activity and a ninefold variation in binding levels of B(a)P binding to DNA were noted in PAM froIm 13 individtals (7) .
In addition to the increase in or mutation frequency, an increase in the number of SCE by either B(a)P or 7,8-diol after their activation by PAM was observed (26) . When the increase in SCE (100% increase over control in 7,8-diol-treated group and 60% increase over control value in B(a)P-treated group) was compared to the frequiency of Or mutation (10-to 100-fold increase over control in the 7,8-diol-treated group and 2-to 10-fold increase in the B(a)P-treated group) it appears that or mutation frequency was a better indicator of PAM metabolic activation than was SCE fre(luency.
In an experiment with a direct-acting ultimate mutagen (carcinogen), B(a)P diol epoxide 1 (27) , a one-to twofold increase in SCE frequency was observed when bromodeoxyuridine was added 2 h after the exposuire of V79 cells.2 Howvever, when bromodeoxyuridine was added 24 h after the exposure to B(a)P diol epoxide I, which has a half-life of <5 min, the increase in fre(quency of SCE was only 20-30% over the control value.3 The SCE frequency of B(a)P diol epoxide I-treated group in Table V is near the control value because bromodeoxyuridine was added to V79 cells 72 h after the initiation of B(a)P diol epoxide I treatment. This finding suggests that SCE may be repaired if bromodeoxyuridine is not added to cells soon after the treatment and that the increased frequency of SCE in V79 cells by the active metabolites may be partly (luenched by the cellular recovery during prolonged cocultivation period with PAM. This may be an explanation for a much greater enhancement of or mutation frequency than on SCE frequency in the PAM-mediated assay.
In conclusion, PAM enzymatically activated B(a)P and 7,8-diol, and released metabolites to the cocultivated 2 Hsu, I. C., G. T. Bowden, and C. C. Harris. 1979 
